Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · IEX Real-Time Price · USD
4.380
+0.150 (3.55%)
Apr 26, 2024, 2:47 PM EDT - Market open
Applied Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for APLT stock have an average target of 11, with a low estimate of 7.00 and a high estimate of 13. The average target predicts an increase of 151.14% from the current stock price of 4.38.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for APLT stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 1 | 1 | 1 | 2 | 3 | 2 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $12 | Buy | Reiterates | $12 | +173.97% | Apr 11, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $12 | Buy | Initiates | $12 | +173.97% | Mar 26, 2024 |
| UBS | UBS | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +196.80% | Mar 15, 2024 |
| UBS | UBS | Strong Buy Maintains $4 → $12 | Strong Buy | Maintains | $4 → $12 | +173.97% | Mar 6, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $12 | Buy | Initiates | $12 | +173.97% | Feb 22, 2024 |
Financial Forecast
Revenue This Year
7.88M
from 9.99M
Decreased by -21.13%
Revenue Next Year
73.43M
from 7.88M
Increased by 831.71%
EPS This Year
-0.73
from -1.42
EPS Next Year
-0.40
from -0.73
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 18.1M | 151.8M | 201.1M |
| Avg | 7.9M | 73.4M | 110.6M |
| Low | 1.7M | 11.6M | 50.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 80.7% | 1,826.3% | 173.9% |
| Avg | -21.1% | 831.7% | 50.6% |
| Low | -82.7% | 47.2% | -31.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.56 | -0.04 | 0.21 |
| Avg | -0.73 | -0.40 | -0.04 |
| Low | -0.80 | -0.69 | -0.18 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.